Dronabinol is assessed being a pregnancy Category C drug, because it hasn't exhibited teratogenic effects in animal types at doses starting from 0.2 to 5 times the maximum advised human dose. Nonetheless, it is important to notice that pregnant patients have not been subjected to adequately